Purple Biotech Operating Expenses Growth & History (PPBT)

Purple Biotech's operating expenses was $27.5M for fiscal 2025.

View full Purple Biotech company overview

Purple Biotech annual operating expenses history

Purple Biotech annual operating expenses

Fiscal yearPeriod endedOperating expensesChangeGrowth
20252025-12-31$27.5M$16.5M+149.50%
20242024-12-31$11.0M−$11.3M−50.59%
20232023-12-31$22.3M−$332,000−1.47%
20222022-12-31$22.6M$4.7M+26.03%
20212021-12-31$17.9M$4.7M+35.46%
20202020-12-31$13.2M$6.6M+98.46%
20192019-12-31$6.7M−$2.2M−24.42%
20182018-12-31$8.8M−$3.2M−26.85%
20172017-12-31$12.1M$4.9M+67.98%
20162016-12-31$7.2M

Purple Biotech operating expenses trends

Over the last five fiscal years, Purple Biotech's operating expenses increased from $13.2M to $27.5M, a change of $14.2M. The latest reported quarter, Q2 2026, shows $1.3M.

About the metric

What operating expenses mean

Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.

Calculation and source

SEC-reported and calculated operating expenses

TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Purple Biotech source filings ↗

Community posts

It’s quiet here.

No posts about PPBT yet. Start the conversation.

Write the first post